Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-25
2010-11-16
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S184000, C546S192000, C546S207000, C546S208000, C514S315000
Reexamination Certificate
active
07834031
ABSTRACT:
The present invention is directed to radiolabeled glycine transporter inhibitors which are useful for the labeling and diagnostic imaging of glycine transporters in mammals.
REFERENCES:
patent: 4931270 (1990-06-01), Horn et al.
patent: 6241964 (2001-06-01), Burns et al.
patent: 6303637 (2001-10-01), Bao et al.
patent: 6458935 (2002-10-01), Burns et al.
patent: 6939966 (2005-09-01), Burns et al.
patent: 7354935 (2008-04-01), Burns et al.
patent: 2007/0105902 (2007-05-01), Lindsley et al.
patent: 2007/0254880 (2007-11-01), Blackaby et al.
patent: WO 2005/046601 (2005-05-01), None
patent: 2005/094514 (2005-10-01), None
Burns H. Donald
Hamill Terence G.
Lindsley Craig W.
Devlin Geened
Merck Sharp & Dohme Corp.
Shameem Golam M
Yuro Raynard
LandOfFree
Radiolabeled glycine transporter inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled glycine transporter inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled glycine transporter inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4209292